Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.82%
SPX
+0.65%
IXIC
+0.67%
FTSE
+0.19%
N225
+1.65%
AXJO
-0.10%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...
Join our newsletter to keep up to date with us!

Key Stats

Market Cap
800.45M
Dividend Yield
0.00%
P/E Ratio
-16.98
EPS
-0.55
Revenue
-
Avg. Volume
568.59K

About

What does AVXL do?
Anavex Life Sciences, a New York-based biopharmaceutical company, develops therapeutics for neurodegenerative diseases and employs 40 staff. Its lead compound, ANAVEX 2-73, targets Alzheimer's and Parkinson's diseases.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
New York, USA
Website
http://www.anavex.com

Recently from Cashu

publisher logo
Cashu

Anavex Life Sciences: Leading Innovation in Neurodegenerative Disease Therapies

2 days ago
publisher logo
Cashu

Anavex Life Sciences: Advancing Neurodegenerative Disease Therapies Amid Biotechnology Challenges

4 days ago
publisher logo
Cashu

Anavex Life Sciences Reacts to Cryoport's Strategic Divestiture and DHL Partnership in Life Sciences

11 days ago
Stocks
Health Care
avxl
Anavex Life Sciences
AVXL
-0.05 (-0.53%)
9.36
USD
At close at Jun 26, 16:41 UTC
Summary
News
Signals
Benchmarks
Financials